- Home
- ROIV vs AR Comparison
ROIV vs AR Comparison
Compare ROIV & AR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AR
- Stock Information
- Founded
- ROIV 2014
- AR 2002
- Country
- ROIV United Kingdom
- AR United States
- Employees
- ROIV N/A
- AR N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AR Oil & Gas Production
- Sector
- ROIV Health Care
- AR Energy
- Exchange
- ROIV Nasdaq
- AR Nasdaq
- Market Cap
- ROIV 8.4B
- AR 9.7B
- IPO Year
- ROIV N/A
- AR 2013
- Fundamental
- Price
- ROIV $11.27
- AR $39.92
- Analyst Decision
- ROIV Strong Buy
- AR Buy
- Analyst Count
- ROIV 8
- AR 18
- Target Price
- ROIV $17.93
- AR $36.29
- AVG Volume (30 Days)
- ROIV 5.1M
- AR 4.5M
- Earning Date
- ROIV 02-11-2025
- AR 02-12-2025
- Dividend Yield
- ROIV N/A
- AR N/A
- EPS Growth
- ROIV N/A
- AR N/A
- EPS
- ROIV 5.89
- AR 0.15
- Revenue
- ROIV $129,128,999.00
- AR $4,272,370,000.00
- Revenue This Year
- ROIV $15.98
- AR N/A
- Revenue Next Year
- ROIV N/A
- AR $18.98
- P/E Ratio
- ROIV $1.91
- AR $273.02
- Revenue Growth
- ROIV 145.68
- AR N/A
- 52 Week Low
- ROIV $9.69
- AR $20.56
- 52 Week High
- ROIV $13.06
- AR $40.93
- Technical
- Relative Strength Index (RSI)
- ROIV 46.46
- AR 74.16
- Support Level
- ROIV $10.89
- AR $37.70
- Resistance Level
- ROIV $11.26
- AR $40.93
- Average True Range (ATR)
- ROIV 0.36
- AR 1.19
- MACD
- ROIV -0.02
- AR 0.38
- Stochastic Oscillator
- ROIV 47.75
- AR 85.06
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AR Antero Resources Corporation
Antero Resources, based in Denver, engages in the exploration for and production of natural gas and natural gas liquids in the United States and Canada. At the end of 2023, the company reported proven reserves of 18.1 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,483 million cubic feet of equivalent a day in 2023 at a ratio of 37% liquids and 63% natural gas.